NCT06040567 Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
| NCT ID | NCT06040567 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rigshospitalet, Denmark |
| Condition | Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
| Study Type | OBSERVATIONAL |
| Enrollment | 520 participants |
| Start Date | 2023-09-23 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 520 participants in total. It began in 2023-09-23 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The project aims to investigate the validity, and reliability of outcome measures of muscle strength, functioning (gait, balance, and fine motor skills), physical activity, and patient-reported outcome measures of functioning (gait, balance, and fine motor skills), and daily living among patients with polyneuropathy. Further, the project aims to compare physical activity and patient-reported outcome measures of functioning (gait, balance, and fine motor skills), and daily living among patients with polyneuropathy with physical activity and patient-reported outcome measures of functioning (gait, balance, and fine motor skills) and daily living in healthy adults.
Eligibility Criteria
Inclusion Criteria: Inclusion Criteria patients: \> 18 years Diagnosed with polyneuropathy (verified by nerve conduction) Inclusion Criteria healthy controls: \> 18 years Healthy Exclusion Criteria: Exclusion Criteria patients: Not verified polyneuropathy Exclusion Criteria healthy controls: Diabetes, brain-, nerve-, muscle-, kidney-, or liver disease. Diagnosed with polyneuropathy
Contact & Investigator
Britt S Pedersen
STUDY CHAIR
Rigshospitalet, University of Copenhagen
Frequently Asked Questions
Who can join the NCT06040567 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06040567 currently recruiting?
Yes, NCT06040567 is actively recruiting participants. Contact the research team at britt.staevnsbo.pedersen.01@regionh.dk for enrollment information.
Where is the NCT06040567 trial being conducted?
This trial is being conducted at Copenhagen, Denmark.
Who is sponsoring the NCT06040567 clinical trial?
NCT06040567 is sponsored by Rigshospitalet, Denmark. The principal investigator is Britt S Pedersen at Rigshospitalet, University of Copenhagen. The trial plans to enroll 520 participants.